| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CERUS CORP | 30,000 | 134,000 | 0.02% | ||
| 2 | SURGERY PARTNERS INCORPORATED | 10,500 | 205,000 | 0.03% | ||
| 3 | MYRIAD GENETICS INC | 13,000 | 250,000 | 0.03% | ||
| 4 | AAC HLDGS INC | 45,000 | 384,000 | 0.05% | ||
| 5 | WEBMD HEALTH CORP | 7,400 | 390,000 | 0.05% | ||
| 6 | NOVAVAX INC COM | 325,000 | 416,000 | 0.06% | ||
| 7 | ACHILLION PHARMACEUTICALS IN | 99,000 | 417,000 | 0.06% | ||
| 8 | PENUMBRA INC COM | 5,000 | 417,000 | 0.06% | ||
| 9 | REWALK ROBOTICS LTD | 200,000 | 420,000 | 0.06% | ||
| 10 | OBALON THERAPEUTICS INC | 40,000 | 428,000 | 0.06% | ||
| 11 | Teladoc, Inc. | 20,000 | 500,000 | 0.07% | ||
| 12 | Theravance Biopharma Inc | 14,428 | 531,000 | 0.07% | ||
| 13 | RESMED INC | 8,000 | 576,000 | 0.08% | ||
| 14 | CELLDEX THERAPEUTICS INC NEW | 160,000 | 578,000 | 0.08% | ||
| 15 | CEMPRA INC | 165,000 | 619,000 | 0.08% | ||
| 16 | INTEGRA LIFESCIENCES HLDGS CP COM NEW | 15,000 | 632,000 | 0.08% | ||
| 17 | VARIAN MED SYS INC | 7,000 | 638,000 | 0.09% | ||
| 18 | INSULET CORPORATION | 15,000 | 646,000 | 0.09% | ||
| 19 | DAVITA INC | 10,000 | 680,000 | 0.09% | ||
| 20 | ALDER BIOPHARMACEUTICALS INC | 33,000 | 686,000 | 0.09% | ||
| 21 | HEALTHCARE SVCS GRP INC | 16,500 | 711,000 | 0.09% | ||
| 22 | GW PHARMACEUTICALS PLC | 6,000 | 726,000 | 0.10% | ||
| 23 | MOLINA HEALTHCARE INC | 16,500 | 752,000 | 0.10% | ||
| 24 | QUOTIENT LTD | 110,000 | 769,000 | 0.10% | ||
| 25 | ENVISION HEALTHCARE HLDGS INC | 13,026 | 799,000 | 0.11% | ||
| 26 | NEVRO CORP COM | 8,700 | 815,000 | 0.11% | ||
| 27 | JUNO THERAPEUTICS INC COM | 37,000 | 821,000 | 0.11% | ||
| 28 | INOVIO PHARMACEUTICALS INC | 144,000 | 953,000 | 0.13% | ||
| 29 | INTERCEPT PHARMACEUTICALS INCORPORATED | 8,500 | 961,000 | 0.13% | ||
| 30 | GLAUKOS CORP | 20,000 | 1,026,000 | 0.14% | ||
| 31 | MEDICINES CO | 21,500 | 1,051,000 | 0.14% | ||
| 32 | UNITED THERAPEUTICS CORP DEL | 7,800 | 1,056,000 | 0.14% | ||
| 33 | KITE PHARMA INCORPORATED | 14,000 | 1,099,000 | 0.15% | ||
| 34 | EXELIXIS INC | 52,000 | 1,127,000 | 0.15% | ||
| 35 | Esperion Therapeutics Inc | 32,000 | 1,130,000 | 0.15% | ||
| 36 | NOVADAQ TECHNOLOGIES INC | 150,000 | 1,169,000 | 0.16% | ||
| 37 | CLOVIS ONCOLOGY INC | 18,500 | 1,178,000 | 0.16% | ||
| 38 | GLOBUS MED INC | 40,000 | 1,185,000 | 0.16% | ||
| 39 | ZELTIQ AESTHETICS INC | 22,000 | 1,223,000 | 0.16% | ||
| 40 | BIOVERATIV INC | 22,750 | 1,239,000 | 0.17% | ||
| 41 | BRISTOL MYERS SQUIBB CO | 23,000 | 1,251,000 | 0.17% | ||
| 42 | TELEFLEX INC | 6,500 | 1,259,000 | 0.17% | ||
| 43 | ENDO INTL PLC | 115,000 | 1,283,000 | 0.17% | ||
| 44 | RADIUS HEALTH INCORPORATED COM NEW | 36,500 | 1,411,000 | 0.19% | ||
| 45 | PORTOLA PHARMACEUTICALS INC | 36,000 | 1,411,000 | 0.19% | ||
| 46 | ACADIA PHARMACEUTICALS INC COM | 45,000 | 1,547,000 | 0.21% | ||
| 47 | CARDINAL HEALTH INC | 20,000 | 1,631,000 | 0.22% | ||
| 48 | PFIZER INC | 50,000 | 1,711,000 | 0.23% | ||
| 49 | Intersect ENT Inc | 100,000 | 1,715,000 | 0.23% | ||
| 50 | MERCK & CO INC | 27,500 | 1,747,000 | 0.23% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-17-004497, filed 2017.05.11).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
